A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy

NCT03304522 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Fiber Neuropathy

Interventions

DRUG: VX-150
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated